Impact of CMV-Specific Immune Reconstitution at the End of Letermovir Prophylaxis on the Development of Late Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients (INMUNOEND)
Clinical trial NCT06814301 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06814301
- Sponsor
- Maimónides Biomedical Research Institute of Córdoba
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-01
- Primary completion
- 2027-06-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.